Moreover, it is also unclear when IL-6 and TNF- α levels become increased in PAD patients with revascularization, if it is directly proximal to the secondary thrombotic event or if they never see a decline in increased IL-6/TNF- α post-surgery. This evidence concerns the gene IL6 and peripheral arterial disease.